Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 5.0S - 11 mm: medical device reports filed with FDA

1,244 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

1,244
device reports naming the brand
0% of all MAUDE reports · about 176 a year
160
reports, 12 months to August 2026
193 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,244 medical device reports received by FDA name the brand "OsseoSpeed TX 5.0S - 11 mm" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

160 reports arrived in the 12 months to August 2026, down 17% from 193 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are loss of osseointegration (35.6%), osseointegration problem (31.8%) and failure to osseointegrate (31%). The patient problems coded most often are failure of implant, inflammation and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01836Sep 2021: 12Oct 2021: 12Nov 2021: 15Dec 2021: 182022Jan 2022: 21Feb 2022: 11Mar 2022: 17Apr 2022: 16May 2022: 12Jun 2022: 10Jul 2022: 7Aug 2022: 22Sep 2022: 11Oct 2022: 13Nov 2022: 6Dec 2022: 132023Jan 2023: 13Feb 2023: 8Mar 2023: 11Apr 2023: 4May 2023: 15Jun 2023: 24Jul 2023: 28Aug 2023: 36Sep 2023: 20Oct 2023: 21Nov 2023: 11Dec 2023: 52024Jan 2024: 22Feb 2024: 19Mar 2024: 14Apr 2024: 28May 2024: 22Jun 2024: 21Jul 2024: 23Aug 2024: 23Sep 2024: 18Oct 2024: 7Nov 2024: 22Dec 2024: 152025Jan 2025: 20Feb 2025: 6Mar 2025: 22Apr 2025: 9May 2025: 10Jun 2025: 14Jul 2025: 25Aug 2025: 25Sep 2025: 13Oct 2025: 7Nov 2025: 12Dec 2025: 72026Jan 2026: 36Feb 2026: 6Mar 2026: 13Apr 2026: 19May 2026: 9Jun 2026: 5Jul 2026: 23Aug 2026: 10

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01693382019: 2620192021: 33820212022: 15920222023: 19620232024: 23420242025: 17020252026: 1212026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,244
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%1,244
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Loss of osseointegration44335.6%22.4%
Osseointegration problem39631.8%7.7%
Failure to osseointegrate38631%62.8%
Fracturea broken bone241.9%1.6%
Insufficient device problem information30.2%0.2%
Difficult to insertthe device was hard to insert20.2%0.4%
Crackthe device cracked10.1%0%
Loosening of implant not related to bone-ingrowth10.1%0.1%
Malposition of device10.1%0.1%
Material deformation10.1%0.1%
Migration or expulsion of device10.1%0%
Off-label use10.1%0%
Patient-device incompatibilitythe device did not suit the patient10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,244100%
Inflammationinflammation20816.7%
Pocket erosion1058.4%
Osteolysis766.1%
Implant pain50.4%
Sinus perforation20.2%
Abscessa collection of pus10.1%
Discomfortdiscomfort10.1%
Inadequate osseointegration10.1%
Swelling/ edema10.1%
Tinnitusringing in the ears10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 5.0S - 11 mmProduct code DZEAll MAUDE reports
Reports1,2443,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 5.0S - 11 mm reports

How many FDA reports name OsseoSpeed TX 5.0S - 11 mm?

1,244 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 160 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

loss of osseointegration (35.6%), osseointegration problem (31.8%), failure to osseointegrate (31%), fracture (1.9%) and insufficient device problem information (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 5.0S - 11 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.